Published in Biomaterials on September 01, 2011
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater (2015) 0.86
Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery. Theranostics (2015) 0.82
Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization. Beilstein J Nanotechnol (2015) 0.81
Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery. Int J Nanomedicine (2012) 0.81
Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo. Theranostics (2016) 0.81
Nanotechnologies for noninvasive measurement of drug release. Mol Pharm (2013) 0.81
Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging (2013) 0.81
Characterization of magnetic viral complexes for targeted delivery in oncology. Theranostics (2015) 0.79
Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery. PLoS One (2013) 0.79
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci U S A (2016) 0.78
Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers. ACS Nano (2013) 0.77
Low toxicity and long circulation time of polyampholyte-coated magnetic nanoparticles for blood pool contrast agents. Sci Rep (2015) 0.76
Biosafe nanoscale pharmaceutical adjuvant materials. J Biomed Nanotechnol (2014) 0.76
Dispersion and Functionalization of Nanoparticles Synthesized by Gas Aggregation Source: Opening New Routes Toward the Fabrication of Nanoparticles for Biomedicine. Langmuir (2015) 0.75
Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast. Ther Deliv (2015) 0.75
Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles. Int J Nanomedicine (2014) 0.75
Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles. Nanoscale Res Lett (2017) 0.75
Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles. Nano Res (2017) 0.75
Synthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermia. Prog Biomater (2017) 0.75
In vivo imaging of siRNA delivery and silencing in tumors. Nat Med (2007) 4.94
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm (2008) 2.90
Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res (2009) 2.28
Molecularly targeted therapy for malignant glioma. Cancer (2007) 1.96
Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci U S A (1998) 1.91
Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A (2010) 1.84
Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience (2004) 1.82
EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res (2010) 1.79
Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol (2011) 1.60
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials (2010) 1.42
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials (2010) 1.33
Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. J Control Release (2007) 1.29
Functional delivery of siRNA in mice using dendriworms. ACS Nano (2009) 1.27
Intraoperative stimulation techniques for functional pathway preservation and glioma resection. Neurosurg Focus (2010) 1.25
Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method. PLoS One (2010) 1.13
Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm (2010) 1.12
Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials (2009) 1.02
Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J (2009) 0.93
A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release (2011) 0.92
Kupffer cell function in host defense. Rev Infect Dis (1988) 0.87
Unintended hepatic adverse events associated with cancer chemotherapy. Toxicol Pathol (2009) 0.81
Targeted therapy for neuro-oncology: reviewing the menu. Drug Discov Today (2008) 0.80
International network of cancer genome projects. Nature (2010) 20.35
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford) (2011) 4.53
Human genomic deletions mediated by recombination between Alu elements. Am J Hum Genet (2006) 3.15
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
BioMart Central Portal: an open database network for the biological community. Database (Oxford) (2011) 3.03
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest (2012) 2.95
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
Alu retrotransposition-mediated deletion. J Mol Biol (2005) 1.79
Genomic rearrangements by LINE-1 insertion-mediated deletion in the human and chimpanzee lineages. Nucleic Acids Res (2005) 1.73
Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol (2011) 1.60
Alu recombination-mediated structural deletions in the chimpanzee genome. PLoS Genet (2007) 1.59
Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging (2012) 1.57
Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging (2011) 1.50
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials (2010) 1.42
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials (2010) 1.33
Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. J Control Release (2007) 1.29
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. PLoS One (2012) 1.27
Different evolutionary fates of recently integrated human and chimpanzee LINE-1 retrotransposons. Gene (2006) 1.26
Identification and characterization of novel polymorphic LINE-1 insertions through comparison of two human genome sequence assemblies. Gene (2006) 1.24
A comparison of the functional modules identified from time course and static PPI network data. BMC Bioinformatics (2011) 1.20
The Fugu tyrp1 promoter directs specific GFP expression in zebrafish: tools to study the RPE and the neural crest-derived melanophores. Pigment Cell Res (2006) 1.17
Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody. J Pharm Sci (2010) 1.15
Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment. Inf Process Med Imaging (2009) 1.15
Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PLoS One (2011) 1.12
Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm (2010) 1.12
Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity. Gene Expr (2004) 1.12
Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α. J Surg Res (2011) 1.11
Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. FASEB J (2005) 1.10
Towards the identification of protein complexes and functional modules by integrating PPI network and gene expression data. BMC Bioinformatics (2012) 1.10
Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Mol Cancer Ther (2012) 1.06
A comparison of the aging and apoptotic transcriptome of Saccharomyces cerevisiae. FEMS Yeast Res (2005) 1.05
Preparation and characterization of a novel electrospun spider silk fibroin/poly(D,L-lactide) composite fiber. J Phys Chem B (2008) 1.04
Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials (2011) 1.04
Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest Ophthalmol Vis Sci (2007) 1.02
Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials (2009) 1.02
Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. Bioorg Med Chem Lett (2005) 1.01
Iteration method for predicting essential proteins based on orthology and protein-protein interaction networks. BMC Syst Biol (2012) 1.01
Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. J Control Release (2011) 1.01
Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas. NMR Biomed (2010) 1.00
Visual display terminal use increases the prevalence and risk of work-related musculoskeletal disorders among Chinese office workers: a cross-sectional study. J Occup Health (2011) 1.00
Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas. J Magn Reson Imaging (2010) 0.99
Osteoblast function on electrically conductive electrospun PLA/MWCNTs nanofibers. Biomaterials (2011) 0.99
Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev (2013) 0.97
Predicting Essential Proteins Based on Weighted Degree Centrality. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.97
DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. PLoS One (2012) 0.96
Diagnosis of multiple primary lung cancer: a systematic review. J Int Med Res (2013) 0.96
Detecting Protein Complexes Based on Uncertain Graph Model. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.96
Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. Biomaterials (2011) 0.95
Diffusion-weighted MRI for assessment of early cancer treatment response. Curr Pharm Biotechnol (2010) 0.94
Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J Gene Med (2003) 0.94
A local average connectivity-based method for identifying essential proteins from the network level. Comput Biol Chem (2011) 0.94
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency. Biochem Biophys Res Commun (2005) 0.93
A two-component histidine kinase Shk1 controls stress response, sclerotial formation and fungicide resistance in Sclerotinia sclerotiorum. Mol Plant Pathol (2013) 0.93
Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J (2009) 0.93
L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release (2009) 0.93
Prediction of essential proteins based on gene expression programming. BMC Genomics (2013) 0.93
A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release (2011) 0.92
Characterization and fitness of carbendazim-resistant strains of Fusarium graminearum (wheat scab). Pest Manag Sci (2007) 0.92
The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection. Biomaterials (2009) 0.92
Identifying the overlapping complexes in protein interaction networks. Int J Data Min Bioinform (2010) 0.91
Synthetic skin-permeable proteins enabling needleless immunization. Angew Chem Int Ed Engl (2010) 0.90
Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A (2013) 0.90
The minimal functional sequence of protamine. Biochem Biophys Res Commun (2005) 0.90
In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J Control Release (2007) 0.90
A Topology Potential-Based Method for Identifying Essential Proteins from PPI Networks. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.90
DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model. NMR Biomed (2011) 0.90
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials (2009) 0.90
Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits. Exp Lung Res (2010) 0.89
Recurrent respiratory papillomatosis: an overview. Eur J Clin Microbiol Infect Dis (2010) 0.89
The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials (2010) 0.89
Imaging proteolytic activity in live cells and animal models. PLoS One (2013) 0.89
Synthesis and characterization of nano-HA/PA66 composites. J Mater Sci Mater Med (2003) 0.88
PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. J Control Release (2009) 0.88
Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system. Pharm Res (2013) 0.88
Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem (2009) 0.88
Evidence for ORC-dependent repression of budding yeast genes induced by starvation and other stresses. FEMS Yeast Res (2006) 0.88
Non-random clustering of stress-related genes during evolution of the S. cerevisiae genome. BMC Evol Biol (2006) 0.87
Plasmid-mediated quinolone resistance--current knowledge and future perspectives. J Int Med Res (2013) 0.87
Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization. J Biomed Mater Res A (2004) 0.87